A carregar...
Radioimmunotherapy Consolidation using (131)I-Tositumomab for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in First Remission
Despite initial responses to chemoimmunotherapy, relapse and minimal residual disease (MRD) remain major issues in treatment of CLL/SLL patients. We administered 131I-tositumomab to patients in CR or PR after induction chemotherapy. Toxicities and rate of PR to CR conversion and MRD elimination were...
Na minha lista:
| Publicado no: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4798884/ https://ncbi.nlm.nih.gov/pubmed/26133724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1067701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|